BG
GMED icon

Bahl & Gaynor’s Globus Medical GMED Stock Holding History

Bahl & Gaynor’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-38,069
Closed -$1.88M – 356
2019
Q1 		$1.88M Buy
38,069
+2,766
+8% +$125K 0.02% 221
2018
Q4 		$1.53M Sell
35,303
-2,578
-7% -$129K 0.02% 218
2018
Q3 		$2.15M Buy
37,881
+350
+0.9% +$18.4K 0.03% 199
2018
Q2 		$1.89M Buy
37,531
+16,961
+82% +$884K 0.02% 220
2018
Q1 		$1.02M Buy
+20,570
New +$967K 0.01% 277

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Bahl & Gaynor's GMED Position: Q2 2019 in Review

Bahl & Gaynor sold out of Globus Medical (GMED) in Q2 2019, closing a stake of 38,069 shares — an estimated $1.88M sold.

Bahl & Gaynor first reported a position in GMED in Q1 2018 and held it in 5 quarters. The position peaked at $2.15M in Q3 2018. 259 funds tracked by Wall St. Rank hold GMED as of Q2 2019.

  • Bahl & Gaynor reported no remaining Globus Medical position as of Q2 2019 after selling out during the quarter.
  • Bahl & Gaynor sold 38,069 Globus Medical shares in Q2 2019, an estimated $1.88M.
  • Bahl & Gaynor first reported a position in Globus Medical in Q1 2018 and held it in 5 quarters.
  • Bahl & Gaynor's Globus Medical position peaked at $2.15M in Q3 2018.
  • 259 funds tracked by Wall St. Rank held Globus Medical as of Q2 2019.

Based on Bahl & Gaynor's 13F filing for Q2 2019, filed 12 Aug 2019.